These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 22288450

  • 1. Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis.
    Alten R.
    Expert Rev Clin Immunol; 2012 Feb; 8(2):123-33. PubMed ID: 22288450
    [Abstract] [Full Text] [Related]

  • 2. Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis.
    Kirwan JR, Clarke L, Hunt LP, Perry MG, Straub RH, Jessop DS.
    Ann N Y Acad Sci; 2010 Apr; 1193():127-33. PubMed ID: 20398018
    [Abstract] [Full Text] [Related]

  • 3. Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis.
    Kirwan JR, Buttgereit F.
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv14-20. PubMed ID: 22685271
    [Abstract] [Full Text] [Related]

  • 4. How should impaired morning function in rheumatoid arthritis be treated?
    Buttgereit F.
    Scand J Rheumatol Suppl; 2011 Jun; 125():28-39. PubMed ID: 21529308
    [Abstract] [Full Text] [Related]

  • 5. Prednisone chronotherapy.
    Spies CM, Cutolo M, Straub RH, Burmester GR, Buttgereit F.
    Clin Exp Rheumatol; 2011 Jun; 29(5 Suppl 68):S42-5. PubMed ID: 22018182
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone.
    Alten R, Döring G, Cutolo M, Gromnica-Ihle E, Witte S, Straub R, Buttgereit F.
    J Rheumatol; 2010 Oct; 37(10):2025-31. PubMed ID: 20682671
    [Abstract] [Full Text] [Related]

  • 7. Circadian rhythms in rheumatology--a glucocorticoid perspective.
    Spies CM, Straub RH, Cutolo M, Buttgereit F.
    Arthritis Res Ther; 2014 Nov 13; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25608777
    [Abstract] [Full Text] [Related]

  • 8. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
    Arthritis Rheum; 2003 Jun 13; 48(6):1504-12. PubMed ID: 12794817
    [Abstract] [Full Text] [Related]

  • 9. Hypothalamic-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with different glucocorticoid approaches.
    Alten R, Wiebe E.
    Neuroimmunomodulation; 2015 Jun 13; 22(1-2):83-8. PubMed ID: 25228310
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M, Foppiani L, Minuto F.
    J Endocrinol Invest; 2002 Jun 13; 25(10 Suppl):19-23. PubMed ID: 12508908
    [Abstract] [Full Text] [Related]

  • 11. Delayed-release prednisone - a new approach to an old therapy.
    Buttgereit F, Gibofsky A.
    Expert Opin Pharmacother; 2013 Jun 13; 14(8):1097-106. PubMed ID: 23594208
    [Abstract] [Full Text] [Related]

  • 12. A fresh look at glucocorticoids how to use an old ally more effectively.
    Buttgereit F.
    Bull NYU Hosp Jt Dis; 2012 Jun 13; 70 Suppl 1():26-9. PubMed ID: 23259655
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids.
    Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, Seriolo B, Giusti M, Accardo S.
    J Rheumatol; 1999 Feb 13; 26(2):282-8. PubMed ID: 9972959
    [Abstract] [Full Text] [Related]

  • 14. Old But Good: Modified-Release Prednisone in Rheumatoid Arthritis.
    Ursini F, Naty S, Bruno C, Grembiale RD.
    Rev Recent Clin Trials; 2017 Feb 13; 12(2):124-128. PubMed ID: 28356031
    [Abstract] [Full Text] [Related]

  • 15. Circadian use of glucocorticoids in rheumatoid arthritis.
    Cutolo M, Sulli A, Pincus T.
    Neuroimmunomodulation; 2015 Feb 13; 22(1-2):33-9. PubMed ID: 25227591
    [Abstract] [Full Text] [Related]

  • 16. Chronobiology and the treatment of rheumatoid arthritis.
    Cutolo M.
    Curr Opin Rheumatol; 2012 May 13; 24(3):312-8. PubMed ID: 22410544
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis.
    Derendorf H, Ruebsamen K, Clarke L, Schaeffler A, Kirwan JR.
    J Clin Pharmacol; 2013 Mar 13; 53(3):326-33. PubMed ID: 23444285
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis.
    Krasselt M, Baerwald C.
    Drug Des Devel Ther; 2016 Mar 13; 10():1047-58. PubMed ID: 27022244
    [Abstract] [Full Text] [Related]

  • 19. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
    Aaronson D, Kaiser H, Dockhorn R, Findlay S, Korenblat P, Thorsson L, Källén A.
    J Allergy Clin Immunol; 1998 Mar 13; 101(3):312-9. PubMed ID: 9525445
    [Abstract] [Full Text] [Related]

  • 20. Circadian rhythms and rheumatoid arthritis.
    Cutolo M.
    Joint Bone Spine; 2019 May 13; 86(3):327-333. PubMed ID: 30227223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.